MedPath

DONQ52

Generic Name
DONQ52

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

Phase 1
Completed
Conditions
Celiac Disease
Interventions
Drug: Placebo
First Posted Date
2022-06-21
Last Posted Date
2025-01-31
Lead Sponsor
Chugai Pharmaceutical
Target Recruit Count
56
Registration Number
NCT05425446
Locations
🇺🇸

Pinnacle Research Group, Anniston, Alabama, United States

🇺🇸

Columbia University Medical Center, New York, New York, United States

🇺🇸

Digestive Specialists Inc, Dayton, Ohio, United States

and more 18 locations
© Copyright 2025. All Rights Reserved by MedPath